Prognostic signs in the evolution of premature thelarche by discriminant analysis.

PubWeight™: 0.78‹?›

🔗 View Article (PMID 1908492)

Published in J Endocrinol Invest on May 01, 1991

Authors

A Tenore1, A Franzese, T Quattrin, M L Sandomenico, G Aloi, P Gallo, A Mariano, S Di Maio

Author Affiliations

1: Dipartimento di Pediatria, II Facoltà di Medicina, Università di Napoli, Italy.

Articles by these authors

Prescription opiate abuse in chronic pain patients: clinical criteria, incidence, and predictors. Clin J Pain (1997) 2.58

Cotherapy with recombinant human insulin-like growth factor I and insulin improves glycemic control in type 1 diabetes. RhIGF-I in IDDM Study Group. Diabetes Care (1999) 2.14

Cerebrospinal fluid in the diagnosis of multiple sclerosis: a consensus report. J Neurol Neurosurg Psychiatry (1994) 1.98

System and market failures: the unavailability of magnesium sulphate for the treatment of eclampsia and pre-eclampsia in Mozambique and Zimbabwe. BMJ (2005) 1.89

The predictive value of gray matter atrophy in clinically isolated syndromes. Neurology (2011) 1.81

A mouse model for hereditary thyroid dysgenesis and cleft palate. Nat Genet (1998) 1.74

Imaging distribution and frequency of cortical lesions in patients with multiple sclerosis. Neurology (2010) 1.72

Evidence for relative cortical sparing in benign multiple sclerosis: a longitudinal magnetic resonance imaging study. Mult Scler (2008) 1.70

Acute myeloid leukemia in Italian patients with multiple sclerosis treated with mitoxantrone. Neurology (2011) 1.68

Production of hemolymphopoietic cytokines (IL-6, IL-8, colony-stimulating factors) by normal human astrocytes in response to IL-1 beta and tumor necrosis factor-alpha. J Immunol (1992) 1.59

Intellectual outcome at 12 years of age in congenital hypothyroidism. Eur J Endocrinol (1999) 1.50

Lipophilic thiamine treatment in long-standing insulin-dependent diabetes mellitus. Acta Diabetol (1999) 1.48

Growth hormone insufficiency in a girl with the autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy. J Endocrinol Invest (1999) 1.43

Increased expression of thyroid hormone receptor isoforms in end-stage human congestive heart failure. J Clin Endocrinol Metab (2001) 1.41

Thrombocytosis in congenital adrenal hyperplasia at diagnosis. Clin Pediatr (Phila) (1996) 1.40

Production of B cell stimulatory factor-2 and interferon gamma in the central nervous system during viral meningitis and encephalitis. Evaluation in a murine model infection and in patients. J Exp Med (1988) 1.40

Lack of efficacy of ursodeoxycholic acid for the treatment of liver abnormalities in obese children. J Pediatr (2000) 1.39

Inflammatory aneurysm of the abdominal aorta. A prospective clinical study. J Cardiovasc Surg (Torino) (1999) 1.39

[Mutism after posterior fossa tumor surgery. Report of 2 cases]. Arq Neuropsiquiatr (1995) 1.37

Class A helix-loop-helix proteins are positive regulators of several cyclin-dependent kinase inhibitors' promoter activity and negatively affect cell growth. Cancer Res (2000) 1.35

Cortical lesions in primary progressive multiple sclerosis: a 2-year longitudinal MR study. Neurology (2009) 1.35

Intracortical lesions: relevance for new MRI diagnostic criteria for multiple sclerosis. Neurology (2010) 1.27

Switching therapy from natalizumab to fingolimod in relapsing-remitting multiple sclerosis: clinical and magnetic resonance imaging findings. Mult Scler (2012) 1.26

Widespread cortical thinning characterizes patients with MS with mild cognitive impairment. Neurology (2010) 1.21

Liver abnormalities in Turner syndrome. Eur J Pediatr (1999) 1.20

Insulin resistance and impaired glucose tolerance in obese children and adolescents from Southern Italy. Nutr Metab Cardiovasc Dis (2006) 1.17

High prevalence of stress hyperglycaemia in children with febrile seizures and traumatic injuries. Acta Paediatr (2001) 1.16

The use of oral mexiletine for the treatment of pain after peripheral nerve injury. Anesthesiology (1992) 1.15

Magnetic resonance evidence of cortical onset of multiple sclerosis. Mult Scler (2009) 1.15

Trade-offs in prenatal detection of Down syndrome. Am J Public Health (1998) 1.15

Electrode positioning for reliable telemetry ECG recordings during social stress in unrestrained rats. Physiol Behav (1996) 1.14

Progressive multiple sclerosis is not associated with chronic cerebrospinal venous insufficiency. Neurology (2011) 1.14

Cortical pathology in multiple sclerosis patients with epilepsy: a 3 year longitudinal study. J Neurol Neurosurg Psychiatry (2011) 1.08

Human parvovirus B19 infection in infancy associated with acute and chronic lymphocytic myocarditis and high cytokine levels: report of 3 cases and review. Clin Infect Dis (2000) 1.08

Knowledge and attitudes regarding preventative HIV vaccine clinical trials in Italy: results of a national survey. AIDS Care (2006) 1.07

Valsartan in acute myocardial infarction trial (VALIANT): rationale and design. Am Heart J (2000) 1.06

The costimulatory molecule B7 is expressed on human microglia in culture and in multiple sclerosis acute lesions. J Neuropathol Exp Neurol (1995) 1.06

Effect of disease-modifying drugs on cortical lesions and atrophy in relapsing-remitting multiple sclerosis. Mult Scler (2011) 1.05

Thyroxine effect on intestinal Cl-/HCO3- exchange in hypo- and hyperthyroid rats. J Endocrinol (1996) 1.04

A computerized data bank of surgical pathology and cytopathology diagnoses. Structure and purposes. Virchows Arch A Pathol Anat Histopathol (1983) 1.03

Home palliative care as a cost-saving alternative: evidence from Catalonia. Palliat Med (2001) 1.02

Transient dwarfism and hypogonadism in mice lacking Otx1 reveal prepubescent stage-specific control of pituitary levels of GH, FSH and LH. Development (1998) 1.02

Quantitation of urinary growth hormone in children with normal and abnormal growth. Pediatr Res (1988) 1.02

Case report of heterotopic bone formation in metastatic carcinoma of the colon. Tumori (1979) 1.01

Tumour necrosis factor-alpha in infectious meningitis. Arch Dis Child (1989) 1.01

Only multiple autoantibodies to islet cells (ICA), insulin, GAD65, IA-2 and IA-2beta predict immune-mediated (Type 1) diabetes in relatives. J Autoimmun (1999) 1.01

Myocyte transdifferentiation: a possible pathogenetic mechanism for arrhythmogenic right ventricular cardiomyopathy. Arch Pathol Lab Med (2000) 1.01

X-linked ichthyosis, due to steroid sulphatase deficiency, associated with Kallmann syndrome (hypogonadotropic hypogonadism and anosmia): linkage relationships with Xg and cloned DNA sequences from the distal short arm of the X chromosome. Hum Genet (1986) 0.99

Effects of immunomodulatory treatment with subcutaneous interferon beta-1a on cognitive decline in mildly disabled patients with relapsing-remitting multiple sclerosis. Mult Scler (2009) 0.99

Frequency of development of acute global left ventricular dysfunction in human immunodeficiency virus infection. J Am Coll Cardiol (1994) 0.98

A survey on Prader-Willi syndrome in the Italian population: prevalence of historical and clinical signs. J Pediatr Endocrinol Metab (2009) 0.97

Influenza virus immunization effectivity in kidney transplant patients subjected to two different triple-drug therapy immunosuppression protocols: mycophenolate versus azathioprine. Transplantation (2000) 0.97

Longitudinal monitoring of bone mineral density in thalassemic patients. Genetic structure and osteoporosis. Acta Paediatr (1997) 0.95

Medicare short-stay hospital length of stay, fiscal years 1981-85. Health Care Financ Rev (1986) 0.95

Clinical and diagnostic aspects of multiple sclerosis and acute monophasic encephalomyelitis in pediatric patients: a single centre prospective study. Mult Scler (2008) 0.95

MODY 2 presenting as neonatal hyperglycaemia: a need to reshape the definition of "neonatal diabetes"? Diabetologia (2000) 0.95

The CDK9-associated cyclins T1 and T2 exert opposite effects on HIV-1 Tat activity. AIDS (1999) 0.95

Gastric emptying delay and gastric electrical derangement in IDDM. Diabetes Care (1998) 0.95

Martsolf's syndrome in a non-Jewish boy. J Med Genet (1988) 0.93

Cytokine regulation of astrocyte function: in-vitro studies using cells from the human brain. Int J Dev Neurosci (1995) 0.93

Interferon-beta (INF-beta) antibodies in interferon-beta1a- and interferon-beta1b-treated multiple sclerosis patients. Prevalence, kinetics, cross-reactivity, and factors enhancing interferon-beta immunogenicity in vivo. Eur Cytokine Netw (2001) 0.92

Severe clinical onset of diabetes and increased prevalence of other autoimmune diseases in children with coeliac disease diagnosed before diabetes mellitus. Diabetologia (2002) 0.92

Urinary JCV-DNA testing during natalizumab treatment may increase accuracy of PML risk stratification. J Neuroimmune Pharmacol (2012) 0.91

Familial and environmental influences on body composition and body fat distribution in childhood in southern Italy. Int J Obes Relat Metab Disord (1994) 0.91

Longitudinal growth, sexual maturation and final height in patients with congenital hypothyroidism detected by neonatal screening. Eur J Endocrinol (2001) 0.91

Growth pattern during the first 36 months of life in congenital adrenal hyperplasia (21-hydroxylase deficiency). Horm Res (1997) 0.91

Model for single-particle dynamics in supercooled water. Phys Rev E Stat Phys Plasmas Fluids Relat Interdiscip Topics (1999) 0.91

Treatment of early-onset multiple sclerosis with intramuscular interferonbeta-1a: long-term results. Neurol Sci (2007) 0.90

A route to explain water anomalies from results on an aqueous solution of salt. J Chem Phys (2010) 0.90

Cardiac-specific overexpression of E40K active Akt prevents pressure overload-induced heart failure in mice by increasing angiogenesis and reducing apoptosis. Cell Death Differ (2007) 0.90

Vertical transmission of the neurofibromatosis/Noonan syndrome. Am J Med Genet (1987) 0.90

Pubertal growth, sexual maturation, and final height in children with IDDM. Effects of age at onset and metabolic control. Diabetes Care (1997) 0.89

Increased CD5+CD19+ B lymphocytes at the onset of type 1 diabetes in children. Acta Diabetol (1997) 0.89

Effects of enzyme-potentiated desensitization in the treatment of pollinosis: a double-blind placebo-controlled trial. J Investig Allergol Clin Immunol (1997) 0.89

Transferrin receptors in rat central nervous system. An immunocytochemical study. J Neurol Sci (1990) 0.89

Aneurysm of the left renal vein: a case report. J Vasc Surg (1994) 0.89

A lentiviral vector with a short troponin-I promoter for tracking cardiomyocyte differentiation of human embryonic stem cells. Gene Ther (2007) 0.89

Frequency and risk factors of mitoxantrone-induced amenorrhea in multiple sclerosis: the FEMIMS study. Mult Scler (2008) 0.88

Disease-modifying drugs in childhood-juvenile multiple sclerosis: results of an Italian co-operative study. Mult Scler (2005) 0.88

[The future of human pathology. Comparison of 2 samples of 1,000 consecutive autopsies performed in the years 1944 and 1974]. Recenti Prog Med (1976) 0.87

Severe EBV hepatitis treated with valganciclovir. Infection (2012) 0.87

Pathological findings of HIV-associated cardiovascular disease. Ann N Y Acad Sci (2001) 0.87

Free light chains in the CSF in multiple sclerosis. J Neurol (1987) 0.87

Determinants of end-stage idiopathic dilated cardiomyopathy: a multivariate analysis of 104 patients. Clin Cardiol (1989) 0.86

Abnormal GH receptor signaling in children with idiopathic short stature. J Clin Endocrinol Metab (2001) 0.86

Diagnostic significance of urinary growth hormone measurements in children with growth failure: correlation between serum and urine growth hormone. Pediatr Res (1991) 0.86

Differential role for Sp1/Sp3 transcription factors in the regulation of the promoter activity of multiple cyclin-dependent kinase inhibitor genes. J Cell Biochem (2000) 0.86

Central precocious puberty: a single blood sample after gonadotropin-releasing hormone agonist administration in monitoring treatment. Horm Res (1998) 0.86

Detection of Brucella species in buffalo whole blood by gene-specific PCR. Vet Rec (2000) 0.86

Natalizumab strongly suppresses cortical pathology in relapsing-remitting multiple sclerosis. Mult Scler (2012) 0.86

Changes in nerve growth factor level and symptom severity following antibiotic treatment for refractory overactive bladder. Int Urogynecol J (2013) 0.85

Increasing frequency of multiple sclerosis in Padova, Italy: a 30 year epidemiological survey. Mult Scler (2003) 0.85

Is apoptosis a diagnostic marker of acute myocardial infarction? Arch Pathol Lab Med (2000) 0.85

Increased CA 125 serum levels in patients with advanced acute leukemia with serosal involvement. Cancer (2000) 0.85

McCune-Albright syndrome: a longitudinal clinical study of 32 patients. J Pediatr Endocrinol Metab (2000) 0.85

The importance of symptom duration in relation to prognosis of carcinoma of the large intestine. Surg Gynecol Obstet (1984) 0.85